Jennifer VanOudenhove1, Tara N Yankee1,2, Andrea Wilderman1,2, Justin Cotney1,3. 1. Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, CT (J.V., T.N.Y., A.W., J.C.). 2. Graduate Program in Genetics and Developmental Biology, UConn Health, Farmington, CT (T.N.Y., A.W.). 3. Institute for Systems Genomics, UConn, Storrs, CT (J.C.).
Abstract
RATIONALE: There is growing evidence that common variants and rare sequence alterations in regulatory sequences can result in birth defects or predisposition to disease. Congenital heart defects are the most common birth defect and have a clear genetic component, yet only a third of cases can be attributed to structural variation in the genome or a mutation in a gene. The remaining unknown cases could be caused by alterations in regulatory sequences. OBJECTIVE: Identify regulatory sequences and gene expression networks that are active during organogenesis of the human heart. Determine whether these sites and networks are enriched for disease-relevant genes and associated genetic variation. METHODS AND RESULTS: We characterized ChromHMM (chromatin state) and gene expression dynamics during human heart organogenesis. We profiled 7 histone modifications in embryonic hearts from each of 9 distinct Carnegie stages (13-14, 16-21, and 23), annotated chromatin states, and compared these maps to over 100 human tissues and cell types. We also generated RNA-sequencing data, performed differential expression, and constructed weighted gene coexpression networks. We identified 177 412 heart enhancers; 12 395 had not been previously annotated as strong enhancers. We identified 92% of all functionally validated heart-positive enhancers (n=281; 7.5× enrichment; P<2.2×10-16). Integration of these data demonstrated novel heart enhancers are enriched near genes expressed more strongly in cardiac tissue and are enriched for variants associated with ECG measures and atrial fibrillation. Our gene expression network analysis identified gene modules strongly enriched for heart-related functions, regulatory control by heart-specific enhancers, and putative disease genes. CONCLUSIONS: Well-connected hub genes with heart-specific expression targeted by embryonic heart-specific enhancers are likely disease candidates. Our functional annotations will allow for better interpretation of whole genome sequencing data in the large number of patients affected by congenital heart defects.
RATIONALE: There is growing evidence that common variants and rare sequence alterations in regulatory sequences can result in birth defects or predisposition to disease. Congenital heart defects are the most common birth defect and have a clear genetic component, yet only a third of cases can be attributed to structural variation in the genome or a mutation in a gene. The remaining unknown cases could be caused by alterations in regulatory sequences. OBJECTIVE: Identify regulatory sequences and gene expression networks that are active during organogenesis of the human heart. Determine whether these sites and networks are enriched for disease-relevant genes and associated genetic variation. METHODS AND RESULTS: We characterized ChromHMM (chromatin state) and gene expression dynamics during human heart organogenesis. We profiled 7 histone modifications in embryonic hearts from each of 9 distinct Carnegie stages (13-14, 16-21, and 23), annotated chromatin states, and compared these maps to over 100 human tissues and cell types. We also generated RNA-sequencing data, performed differential expression, and constructed weighted gene coexpression networks. We identified 177 412 heart enhancers; 12 395 had not been previously annotated as strong enhancers. We identified 92% of all functionally validated heart-positive enhancers (n=281; 7.5× enrichment; P<2.2×10-16). Integration of these data demonstrated novel heart enhancers are enriched near genes expressed more strongly in cardiac tissue and are enriched for variants associated with ECG measures and atrial fibrillation. Our gene expression network analysis identified gene modules strongly enriched for heart-related functions, regulatory control by heart-specific enhancers, and putative disease genes. CONCLUSIONS: Well-connected hub genes with heart-specific expression targeted by embryonic heart-specific enhancers are likely disease candidates. Our functional annotations will allow for better interpretation of whole genome sequencing data in the large number of patients affected by congenital heart defects.
Authors: Laura E DeMare; Jing Leng; Justin Cotney; Steven K Reilly; Jun Yin; Richard Sarro; James P Noonan Journal: Genome Res Date: 2013-05-23 Impact factor: 9.043
Authors: Ashish Kapoor; Dongwon Lee; Luke Zhu; Elsayed Z Soliman; Megan L Grove; Eric Boerwinkle; Dan E Arking; Aravinda Chakravarti Journal: Proc Natl Acad Sci U S A Date: 2019-05-08 Impact factor: 11.205
Authors: D W Benson; G M Silberbach; A Kavanaugh-McHugh; C Cottrill; Y Zhang; S Riggs; O Smalls; M C Johnson; M S Watson; J G Seidman; C E Seidman; J Plowden; J D Kugler Journal: J Clin Invest Date: 1999-12 Impact factor: 14.808
Authors: Jason Homsy; Samir Zaidi; Yufeng Shen; James S Ware; Kaitlin E Samocha; Konrad J Karczewski; Steven R DePalma; David McKean; Hiroko Wakimoto; Josh Gorham; Sheng Chih Jin; John Deanfield; Alessandro Giardini; George A Porter; Richard Kim; Kaya Bilguvar; Francesc López-Giráldez; Irina Tikhonova; Shrikant Mane; Angela Romano-Adesman; Hongjian Qi; Badri Vardarajan; Lijiang Ma; Mark Daly; Amy E Roberts; Mark W Russell; Seema Mital; Jane W Newburger; J William Gaynor; Roger E Breitbart; Ivan Iossifov; Michael Ronemus; Stephan J Sanders; Jonathan R Kaltman; Jonathan G Seidman; Martina Brueckner; Bruce D Gelb; Elizabeth Goldmuntz; Richard P Lifton; Christine E Seidman; Wendy K Chung Journal: Science Date: 2015-12-04 Impact factor: 47.728
Authors: Abhinav Nellore; Leonardo Collado-Torres; Andrew E Jaffe; José Alquicira-Hernández; Christopher Wilks; Jacob Pritt; James Morton; Jeffrey T Leek; Ben Langmead Journal: Bioinformatics Date: 2017-12-15 Impact factor: 6.937
Authors: Sheng Chih Jin; Jason Homsy; Samir Zaidi; Qiongshi Lu; Sarah Morton; Steven R DePalma; Xue Zeng; Hongjian Qi; Weni Chang; Michael C Sierant; Wei-Chien Hung; Shozeb Haider; Junhui Zhang; James Knight; Robert D Bjornson; Christopher Castaldi; Irina R Tikhonoa; Kaya Bilguvar; Shrikant M Mane; Stephan J Sanders; Seema Mital; Mark W Russell; J William Gaynor; John Deanfield; Alessandro Giardini; George A Porter; Deepak Srivastava; Cecelia W Lo; Yufeng Shen; W Scott Watkins; Mark Yandell; H Joseph Yost; Martin Tristani-Firouzi; Jane W Newburger; Amy E Roberts; Richard Kim; Hongyu Zhao; Jonathan R Kaltman; Elizabeth Goldmuntz; Wendy K Chung; Jonathan G Seidman; Bruce D Gelb; Christine E Seidman; Richard P Lifton; Martina Brueckner Journal: Nat Genet Date: 2017-10-09 Impact factor: 38.330
Authors: Chukwuemeka G Anene-Nzelu; Mick C J Lee; Wilson L W Tan; Albert Dashi; Roger S Y Foo Journal: Nat Rev Cardiol Date: 2021-08-11 Impact factor: 32.419
Authors: Anthony M Pettinato; Dasom Yoo; Jennifer VanOudenhove; Yu-Sheng Chen; Rachel Cohn; Feria A Ladha; Xiulan Yang; Ketan Thakar; Robert Romano; Nicolas Legere; Emily Meredith; Paul Robson; Michael Regnier; Justin L Cotney; Charles E Murry; J Travis Hinson Journal: Cell Rep Date: 2021-05-04 Impact factor: 9.423
Authors: Tomoya Sakamoto; Kirill Batmanov; Shibiao Wan; Yuanjun Guo; Ling Lai; Rick B Vega; Daniel P Kelly Journal: Nat Commun Date: 2022-04-13 Impact factor: 14.919